<?xml version="1.0" encoding="UTF-8"?>
<ref id="B15-ijms-22-00634">
 <label>15.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lu</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Gad</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Wenner</surname>
    <given-names>C.A.</given-names>
   </name>
   <name>
    <surname>Chang</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Larson</surname>
    <given-names>E.R.</given-names>
   </name>
   <name>
    <surname>Dang</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Martzen</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Standish</surname>
    <given-names>L.J.</given-names>
   </name>
   <name>
    <surname>Disis</surname>
    <given-names>M.L.</given-names>
   </name>
  </person-group>
  <article-title>Polysaccharide Krestin is a novel TLR2 agonist that mediates inhibition of tumor growth via stimulation of CD8 T cells and NK cells</article-title>
  <source>Clin. Cancer. Res.</source>
  <year>2011</year>
  <volume>17</volume>
  <fpage>67</fpage>
  <lpage>76</lpage>
  <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-10-1763</pub-id>
  <?supplied-pmid 21068144?>
  <pub-id pub-id-type="pmid">21068144</pub-id>
 </element-citation>
</ref>
